Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v1-EN
Language English English
Date Updated 2020-07-14 2019-12-10
Drug Identification Number 02126680 02126680
Brand name CARBOPLATIN INJECTION BP CARBOPLATIN INJECTION BP
Common or Proper name CARBOPLATIN CARBOPLATIN
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients CARBOPLATIN CARBOPLATIN
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5mL vial 5mL vial
ATC code L01XA L01XA
ATC description OTHER ANTINEOPLASTIC AGENTS OTHER ANTINEOPLASTIC AGENTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2020-01-31
Actual start date 2020-01-31
Estimated end date 2020-05-31
Actual end date 2020-07-13
Shortage status Resolved Anticipated shortage
Tier 3 Status No No
Company comments Other presentations remain available.
Health Canada comments